RPTX
Repare Therapeutics Inc
NASDAQ: RPTX · HEALTHCARE · BIOTECHNOLOGY
$2.65
+0.00% today
Updated 2026-01-28
Market cap
$114.24M
P/E ratio
—
P/S ratio
9.62x
EPS (TTM)
$-1.70
Dividend yield
—
52W range
$1 – $3
Volume
1.4M
Repare Therapeutics Inc (RPTX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |